Related Experiment Video
Updated: Aug 22, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Sudden cardiac death in chronic kidney disease and dialysis: From descriptive epidemiology to mechanism-driven
Carmine Zoccali1,2,3, Mehmet Kanbay4, Andrzej Wiecek5
1Renal Research Institute, New York, New York, USA.
Insights
Sudden cardiac death (SCD) in chronic kidney disease (CKD) patients on dialysis is common. New research shows arrhythmias are diverse, and prevention strategies should target myocardial substrate, electrophysiology, and dialysis triggers.
Area of Science:
- Nephrology
- Cardiology
- Electrophysiology
Background:
- Sudden cardiac death (SCD) is a major cause of mortality in chronic kidney disease (CKD), especially in dialysis patients.
- SCD accounts for a significant portion of deaths and cardiovascular mortality in hemodialysis patients, often clustering around dialysis sessions.
- Traditional views focused on ventricular tachyarrhythmias, but recent data reveal a broader spectrum including bradyarrhythmias and conduction disease.
Purpose of the Study:
- To review epidemiologic, mechanistic, and interventional data on SCD in CKD and dialysis.
- To emphasize insights from device-based studies and modifiable factors in SCD prevention.
- To propose a framework for SCD prevention in CKD patients.
Main Methods:
- Narrative, non-systematic review of existing literature.
- Synthesis of data from implantable loop recorder and implantable cardioverter-defibrillator studies.
- Analysis of modifiable dialytic and pharmacologic factors influencing SCD risk.
Main Results:
- SCD in CKD/dialysis involves a heterogeneous arrhythmic spectrum, not solely ventricular tachyarrhythmias.
- Bradyarrhythmias and conduction system disease are frequent contributors to SCD.
- A prevention framework involves managing myocardial substrate, electrophysiologic milieu, and dialysis triggers.
Conclusions:
- SCD prevention in CKD requires a multifactorial approach.
- Integrating CKD and heart failure therapies, individualized dialysis, and device therapy can mitigate risk.
- Improved phenotyping, monitoring, and risk stratification are crucial for effective SCD risk modification in CKD.
Abstract:
Sudden cardiac death (SCD) is a leading cause of mortality across the chronic kidney disease (CKD) continuum and becomes particularly prominent in dialysis-dependent kidney failure. In hemodialysis, SCD accounts for roughly one quarter to one third of all deaths and up to 60%-75% of cardiovascular mortality, with marked temporal clustering around the long interdialytic interval and the first post-interval session. Traditional views have emphasized descriptive epidemiology and presumed ventricular tachyarrhythmias. More recent device-based studies challenge this paradigm, revealing a heterogeneous arrhythmic spectrum in which bradyarrhythmias, pauses, and conduction system disease are often at least as frequent as sustained ventricular tachycardia or fibrillation. This narrative, non-systematic review synthesizes epidemiologic, mechanistic, and interventional data on SCD in CKD and dialysis, with particular emphasis on insights from implantable loop recorder and implantable cardioverter-defibrillator cohorts and on modifiable dialytic and pharmacologic factors. A framework for prevention is proposed around three interacting domains: the structural myocardial substrate, the electrophysiologic milieu, and dialysis-related triggers. Within this framework, contemporary heart failure and CKD therapies (including sodium-glucose cotransporter 2 inhibitors, angiotensin receptor-neprilysin inhibitors, mineralocorticoid receptor antagonists, and beta-blockers), individualized dialysis prescriptions (targeting potassium, calcium, bicarbonate, ultrafiltration, and scheduling), and selective use of device therapy are considered complementary components of mechanism-driven SCD prevention. Methodological challenges in defining and adjudicating SCD in CKD are discussed, and priorities are outlined for improved phenotyping, continuous rhythm monitoring, and CKD-specific risk stratification, with the overarching aim of moving from descriptive statistics to effective risk modification.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
